Petteway Stephen R Jr
Executive VP, R&D at Talecris Biotherapeutics Holdings Corp.
- Sold, on record
- $3.5M
- Dollars the filings state
- Form 4 sales
- 6
- Latest Feb 1, 2011
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Talecris Biotherapeutics Holdings Corp.Executive VP, R&D
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Talecris Biotherapeutics Holdings Corp.UnusualSep 1 2010
Sold 25,000 shares at $21.99 ($550k)
Petteway Stephen R Jr, Executive VP, R&D
Sold 27.7% of holdings ($2M position)65,198 shares leftFirst sale on recordFiling
- 2 Form 4 sale Talecris Biotherapeutics Holdings Corp.UnusualOct 1 +30 days
Sold 25,000 shares at $22.81 ($570k)
Petteway Stephen R Jr, Executive VP, R&D
Sold 29.3% of holdings ($1.9M position)60,198 shares leftFiling
- 3 Form 4 sale Talecris Biotherapeutics Holdings Corp.UnusualNov 1 +31 days
Sold 25,000 shares at $24.37 ($609k)
Petteway Stephen R Jr, Executive VP, R&D
Sold 31.2% of holdings ($2M position)55,198 shares leftFiling
- 4 Form 4 sale Talecris Biotherapeutics Holdings Corp.UnusualDec 1 +30 days
Sold 25,000 shares at $21.50 ($538k)
Petteway Stephen R Jr, Executive VP, R&D
Sold 33.2% of holdings ($1.6M position)50,198 shares left1x usual sizeFiling
- 5 Form 4 sale Talecris Biotherapeutics Holdings Corp.UnusualJan 3 +33 days
Sold 25,000 shares at $23.06 ($577k)
Petteway Stephen R Jr, Executive VP, R&D
Sold 35.6% of holdings ($1.6M position)45,198 shares left1x usual sizeFiling
- 6 Form 4 sale Talecris Biotherapeutics Holdings Corp.UnusualFeb 1 +29 days
Sold 25,000 shares at $24.37 ($609k)
Petteway Stephen R Jr, Executive VP, R&D
Sold 38.3% of holdings ($1.6M position)40,198 shares left1x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (6)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Feb 1, 2011 | Talecris Biotherapeutics Holdings Corp. | Executive VP, R&D | Form 4 sale | 25,000 | $609k | 38.3% | Unusual | SEC |
| Jan 3, 2011 | Talecris Biotherapeutics Holdings Corp. | Executive VP, R&D | Form 4 sale | 25,000 | $577k | 35.6% | Unusual | SEC |
| Dec 1, 2010 | Talecris Biotherapeutics Holdings Corp. | Executive VP, R&D | Form 4 sale | 25,000 | $538k | 33.2% | Unusual | SEC |
| Nov 1, 2010 | Talecris Biotherapeutics Holdings Corp. | Executive VP, R&D | Form 4 sale | 25,000 | $609k | 31.2% | Unusual | SEC |
| Oct 1, 2010 | Talecris Biotherapeutics Holdings Corp. | Executive VP, R&D | Form 4 sale | 25,000 | $570k | 29.3% | Unusual | SEC |
| Sep 1, 2010 | Talecris Biotherapeutics Holdings Corp. | Executive VP, R&D | Form 4 sale | 25,000 | $550k | 27.7% | Unusual | SEC |